Health Promotion Perspectives最新文献

{"title":"Dietary linoleic acid intake in relation to breast cancer: A case-control study.","authors":"Muhammad Reza Joya,&nbsp;Sina Naghshi,&nbsp;Omid Sadeghi,&nbsp;Sanaz Benisi-Kohansal,&nbsp;Leila Azadbakht,&nbsp;Keyhan Lotfi,&nbsp;Alireza Ostadrahimi,&nbsp;Helda Tutunchi,&nbsp;Ahmad Esmaillzadeh","doi":"10.34172/hpp.2023.27","DOIUrl":"10.34172/hpp.2023.27","url":null,"abstract":"<p><strong>Background: </strong>The present study aimed to investigate the association between dietary linoleic acid (LA) intake and breast cancer in women.</p><p><strong>Methods: </strong>In this population-based case-control study, we enrolled 350 pathologically confirmed breast cancer cases and 700 controls which were matched with cases in terms of age and socioeconomic status. Dietary intakes were assessed using a 106-item Willett-format semi-quantitative dish-based food frequency questionnaire (DS-FFQ). Odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were estimated.</p><p><strong>Results: </strong>A significant inverse association was found between LA intake and odds of breast cancer (OR: 0.41, 95% CI: 0.30-0.56). After adjusting for potential confounders, women in the highest tertile of dietary LA intake were 48% less likely to have breast cancer compared with those in the lowest tertile (OR: 0.52, 95% CI: 0.28-0.95). Such a significant inverse association was also seen among normal-weight women (OR: 0.29, 95% CI: 0.14-0.63), and premenopausal women (OR: 0.15, 95% CI: 0.02-0.95).</p><p><strong>Conclusion: </strong>The findings of current study provide evidence for a protective role of LA against breast cancer particularly among normal-weight and premenopausal women. Prospective studies are needed to confirm this association.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":"13 3","pages":"219-226"},"PeriodicalIF":4.4,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558966/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41153153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Medications Non-adherence Reasoning Scale (MedNARS): Development and psychometric properties appraisal.","authors":"Hamid Allahverdipour,&nbsp;Majid Badri,&nbsp;Abdolreza Shaghaghi,&nbsp;Hassan Mahmoodi,&nbsp;Haleh Heizomi,&nbsp;Shayesteh Shirzadi,&nbsp;Mohammad Asghari-Jafarabadi","doi":"10.34172/hpp.2023.26","DOIUrl":"10.34172/hpp.2023.26","url":null,"abstract":"<p><strong>Background: </strong>Proper elucidation of medication non-adherence reasoning especially in older adults might pave the way for an auspicious therapeutic outcome. The main aim of this study was to develop and psychometrically test the Medications Non-adherence Reasoning (MedNARS) questionnaire for application in research and probably practice settings.</p><p><strong>Methods: </strong>A mixed methods design was utilized to develop the MedNARS. The item pool was mainly generated based on a qualitative query and literature review. The expert panel approved version of the MedNARS was psychometrically assessed on a convenience sample of 220 older patients with chronic disease. The internal consistency, test-retest reliability, content and face validity of the scale were appraised and its construct validity was assed using exploratory and confirmatory factor analyses.</p><p><strong>Results: </strong>A nine-item version of the MedNARS was drafted based on the classical item analysis procedures and its estimated internal consistency measure of the Cronbach's alpha (0.85) and test-retest reliability (0.96) were in the vicinity of acceptable range. The exploratory factor analysis (EFA) output revealed a unidimensional structure for the MedNARS and the conducted confirmatory factor analysis (CFA) indicated an acceptable data fit for the extracted one-factor model. The goodness of fit indices were as the followings: χ² /df=1.63(90% CI: 0.02 to 0.11), root mean squared error of approximation (RMSEA)=(0.07), comparative fit index (CFI)=0.95, Tucker-Lewis index (TLI)=0.93 and standardized root mean squared residual (SRMSR)=(0.05).</p><p><strong>Conclusion: </strong>The study findings were indicative of MedNARS's applicability and feasibility for use in assessment of medication non-adherence reasoning among the elderly patients with chronic diseases. The MedNARS as a brief and elder-friendly instrument can be applied both in research and practice settings to enhance efficiency, safety, and health outcomes of the therapeutic recommendations.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":"13 3","pages":"212-218"},"PeriodicalIF":4.4,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558970/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41173315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Preparing for future outbreaks in Ghana: An overview of current COVID-19, monkeypox, and Marburg disease outbreaks.","authors":"Isaac Owusu,&nbsp;Collins Adu,&nbsp;Richard Gyan Aboagye,&nbsp;Rebecca Ann Mpangah,&nbsp;Gideon K Acheampong,&nbsp;Ernest Akyereko,&nbsp;Emmanuel Osei Bonsu,&nbsp;Prince Peprah","doi":"10.34172/hpp.2023.25","DOIUrl":"10.34172/hpp.2023.25","url":null,"abstract":"<p><p>Amidst the ongoing COVID-19 pandemic, Ghana is currently grappling with simultaneous outbreaks of Marburg virus disease and human monkeypox virus. The coexistence of these outbreaks emphasizes the imperative for a collaborative and global approach to enhance surveillance and expedite case detection. While Ghana has made efforts to respond to these outbreaks, this paper outlines the lessons learned and proposes recommendations in this regard. It is crucial to intensify response efforts at the local, regional, and national levels to effectively contain the spread of these infectious diseases. Therefore, this paper suggests prioritizing the following recommendations as crucial for assisting Ghana in adequately preparing for future outbreaks and safeguarding global public health: strengthening surveillance system through digitization, rapid and effective response; risk communication and community engagement; healthcare system readiness; and research and collaboration. Also, prioritizing building healthy public policies and developing personal skills of health personnel across the country is key for future outbreak response.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":"13 3","pages":"202-211"},"PeriodicalIF":4.4,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558975/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41134498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring the role of ChatGPT in patient care (diagnosis and treatment) and medical research: A systematic review","authors":"R. Garg, V. L. Urs, Akshya Anand Agrawal, Sarvesh Kumar Chaudhary, V. Paliwal, Sujita Kumar Kar","doi":"10.1101/2023.06.13.23291311","DOIUrl":"https://doi.org/10.1101/2023.06.13.23291311","url":null,"abstract":"Background ChatGPT(Chat Generative Pre-trained Transformer) is an artificial intelligence (AI) based on a natural language processing tool developed by OpenAI (California, USA). This systematic review examines the potential of Chat GPT in diagnosing and treating patients and its contributions to medical research. Methods In order to locate articles on ChatGPT's use in clinical practise and medical research, this systematic review used PRISMA standards and conducted database searches across several sources. Selected records were analysed using ChatGPT, which also produced a summary for each article. The resultant word document was transformed to a PDF and handled using ChatPDF. The review looked at topics pertaining to scholarly publishing, clinical practise, and medical research. Results We reviewed 118 publications. There are difficulties and moral conundrums associated with using ChatGPT in therapeutic settings and medical research. Patient inquiries, note writing, decision-making, trial enrolment, data management, decision support, research support, and patient education are all things that ChatGPT can help with. However, the solutions it provides are frequently inadequate and inconsistent, presenting issues with its originality, privacy, accuracy, bias, and legality. When utilising ChatGPT for academic writings, there are issues with prejudice and plagiarism, and because it lacks human-like characteristics, its authority as an author is called into question. Conclusions ChatGPT has limitations when used in research and healthcare. Even while it aids in patient treatment, concerns regarding accuracy, authorship, and bias arise. Currently, ChatGPT can serve as a \"clinical assistant\" and be a huge assistance with research and scholarly writing.","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":"13 1","pages":"183 - 191"},"PeriodicalIF":4.4,"publicationDate":"2023-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43770643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"COVID-19 vaccine hesitancy: A Systematic review of cognitive determinants.","authors":"Sara Pourrazavi,&nbsp;Zahra Fathifar,&nbsp;Manoj Sharma,&nbsp;Hamid Allahverdipour","doi":"10.34172/hpp.2023.03","DOIUrl":"10.34172/hpp.2023.03","url":null,"abstract":"<p><p><b>Background:</b> Although mass vaccination is considered one of the most effective public health strategies during the pandemic, in the COVID-19 era, many people considered vaccines unnecessary and, or doubted the effectiveness of the COVID-19 vaccine. This review aimed to tabulate cognitive causes of COVID-19 vaccination hesitancy, which may help public health policymakers overcome the barriers to mass vaccinations in future pandemics. <b>Methods:</b> For this systematic review, studies pertaining to COVID-19 vaccine hesitancy published up to June 2022 were retrieved from six online databases (Cochrane Library, Google Scholar Medline through PubMed, Scopus, and Web of Science). Inclusion criteria were the studies conducted on people who had a delay in accepting or refusing COVID-19 vaccines, reported the impact of cognitive determinants on vaccine hesitancy, and were written in English in the timeframe of 2020-2022. <b>Results:</b> This systematic review initially reviewed 1171 records. From these 91 articles met the inclusion criteria. The vaccination hesitation rate was 29.72% on average. This systematic review identified several cognitive determinants influencing vaccination hesitancy. Lack of confidence and complacency were the most frequent factors that predicted vaccine hesitancy. <b>Conclusion:</b> The identified prevailing cognitive determinants for COVID-19 vaccine hesitancy indicated that using initiative and effective communication strategies would be a determinant factor in building people's trust in vaccines during the pandemic and mass vaccinations.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":"13 1","pages":"21-35"},"PeriodicalIF":4.4,"publicationDate":"2023-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257562/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9629823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Use and outcomes of antihypertensive medication treatment in the US hypertensive population: A gender comparison.","authors":"Shakir Ullah,&nbsp;Shahbaz Khan,&nbsp;Shahrzad Bazargan-Hejazi,&nbsp;Ernesto Ramirez,&nbsp;Senait Teklehaimanot,&nbsp;Sara Diab,&nbsp;Maria Bangash,&nbsp;Magda Shaheen","doi":"10.34172/hpp.2023.17","DOIUrl":"https://doi.org/10.34172/hpp.2023.17","url":null,"abstract":"<p><strong>Background: </strong>Although effective antihypertensive medications have existed for decades, only about half of the hypertensive individuals are considered to have controlled blood pressure. Limited research studies have investigated gender disparity in the utilization and effectiveness of antihypertensive medications treatment. To examine the gender difference in antihypertensive medications' use and the effect of using antihypertensive medication treatment on blood pressure control among the U.S. adult with hypertension.</p><p><strong>Methods: </strong>Analysis of National Health and Nutrition Examination Survey (NHANES) data from (1999-2012) including individuals≥18 years old with hypertension. Study variables included gender, age, race/ethnicity, obesity, smoking, comorbidities, treatment medication type, and continuity of care. We used multivariate logistic regression in STATA V14. The data is presented as adjusted odds ratios (ORs) and 95% confidence interval (CI).</p><p><strong>Results: </strong>Of the 15719 participants, 52% were female. 49% of the antihypertensive medication users had their blood pressure under control (95% CI). In the adjusted logistic regression analysis, use of antihypertensive medications was found to be 12% greater in females as compared to males (OR=1.12; CI=1.02-1.22; <i>P</i><0.05). No association between gender and blood pressure control was found. Blood pressure control was less likely achieved among 50 years or younger individuals, Blacks and Hispanics, obese, and those taking calcium channel blocker (CCB).</p><p><strong>Conclusion: </strong>Hypertensive females are more likely than males to use antihypertensive medications. The effectiveness of treatment to control blood pressure is equal across males and females. Our findings have implications for practitioners to account gender-specific approaches when discussing adherence to hypertension medication treatment with their patients.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":"13 2","pages":"140-146"},"PeriodicalIF":4.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439450/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10046187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Understanding the role of intimate partner violence on HIV transmission in Zimbabwe: Secondary data analysis of data from the Zimbabwe demographic survey 2015-2016.","authors":"Munyaradzi Mapingure,&nbsp;Tafadzwa Dzinamarira,&nbsp;Zindoga Mukandavire,&nbsp;Innocent Chingombe,&nbsp;Diego F Cuadros,&nbsp;Rouzeh Eghtessadi,&nbsp;Farirai Mutenherwa,&nbsp;Helena Herrera,&nbsp;Roda Madziva,&nbsp;Solomon Mukwenha,&nbsp;Grant Murewanhema,&nbsp;Godfrey Musuka","doi":"10.34172/hpp.2023.14","DOIUrl":"https://doi.org/10.34172/hpp.2023.14","url":null,"abstract":"<p><strong>Background: </strong>Gender-based violence (GBV) has been shown to have significant and long-lasting impacts on women's physical and mental health. It is, therefore, important to study its occurrence in a population and its intersect with infectious diseases such as HIV to inform the wider health promotion agenda. This study aimed to determine the association between GBV and HIV status in women and adolescent girls in Zimbabwe.</p><p><strong>Methods: </strong>A secondary data analysis of data from a cross-sectional Zimbabwe Demographic and Health Survey (ZDHS) was conducted. Statistical analysis was employed to establish the association between GBV and HIV status. Geospatial mapping was conducted using a kernel smoothing method was employed to generate a continuous kernel density surface to illustrate the local spatial variations of female HIV and GBV prevalence.</p><p><strong>Results: </strong>Women and adolescent girls suffering emotional GBV, such as those subjected to humiliation by their husbands or partners, were 1.45 (1.14-1.84) [OR (95% CIs)] times more likely to be HIV positive than those who were never humiliated. The same was true for women and adolescent girls whose husbands or partners threatened to harm them or someone they love, 1.33 (1.04-1.68). There is a relationship between women's HIV status and intimate partner aggression, such as when their partners pushed, shook, or threw something at them or physically abused them. This was also the case for those who reported that partners kicked, dragged, or beat them, tried to choke or burn them on purpose, or threatened or attacked them with a knife, gun, or other weapons. Women who experienced forced sexual violence with threats were more likely 1.61 (1.08-2.41), to be HIV positive than those women who did not experience the same.</p><p><strong>Conclusion: </strong>GBV is widely spread in Zimbabwe. There is a need for the government to implement creative strategies to reach out to survivors, especially those that are forced to have unprotected sex and are at increased risk of HIV acquisition. This manuscript raises issues that can be addressed by robust health promotion strategies to reduce the impact of the syndemic of GBV and HIV acquisition in Zimbabwe.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":"13 2","pages":"113-119"},"PeriodicalIF":4.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439455/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10039802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Catastrophic health expenditures in hospitalized patients with delta variant of COVID-19: A cross-sectional study.","authors":"Zahra Gheinali,&nbsp;Esmaeil Moshiri,&nbsp;Masoumeh Ebrahimi Tavani,&nbsp;Mehdi Haghi,&nbsp;Farid Gharibi","doi":"10.34172/hpp.2023.09","DOIUrl":"https://doi.org/10.34172/hpp.2023.09","url":null,"abstract":"<p><p><b>Background:</b> Financial protection of populations against healthcare costs is one of the fundamental responsibilities of governments. This study aimed to investigate the incidence of catastrophic health expenditures (CHE) and it's affecting factors in hospitalized patients with delta variant of COVID-19. <b>Methods:</b> In this cross-sectional study, we included 400 hospitalized COVID-19 patients at Kosar Hospital of Semnan in 2022, using a researcher-made checklist. Based on qualitative nature of the variables, chi-square test was used to investigate the statistical associations between the demographic/background characteristics and the incidence of CHE. <b>Results:</b> On average, COVID-19 imposed 1833.43 USD direct medical costs per one hospitalized patient. The ratio of direct-medical costs to household's non-food expenses was 2.35, and 61% (CI:±4.78%) of the patients were subject to CHE. Besides, residence place, basic insurance type, benefitting from supplementary insurance, suffering from underlying diseases, hospitalization in ICU, falling into a coma, facing pulmonary failure, and performing hemoperfusion had significant associations with CHE (<i>P</i><0.05). <b>Conclusion:</b> The incidence of CHE in hospitalized COVID-19 patients was undesirable, which may be due to geographical, economical, and occupational inequalities apart from the factors related to the severity of the disease. So, health policymakers should pay attention to the provision of proper financial risk protection policies to make the health insurance system more efficient and appropriate.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":"13 1","pages":"68-76"},"PeriodicalIF":4.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9627319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Monkeypox: A review of a zoonotic disease of global public health concern.","authors":"Yusuf Amuda Tajudeen,&nbsp;Habeebullah Jayeola Oladipo,&nbsp;Abdulbasit Opeyemi Muili,&nbsp;Joy Ginika Ikebuaso","doi":"10.34172/hpp.2023.01","DOIUrl":"https://doi.org/10.34172/hpp.2023.01","url":null,"abstract":"<p><p><b>Background:</b> The rising circulation of the monkeypox virus while the COVID-19 is still ongoing in non-endemic countries is a significant global health threat. In this article, we have discussed the epidemiology, aetiology, and pathogenesis of the monkeypox virus to provide our current knowledge of the disease. Also, we discussed the ongoing efforts of the international health organizations to curtail the present epidemic and we finally provide recommendations for early detection and response. <b>Methods:</b> We did a rapid literature search on PubMed, EMBASE, World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), and other trusted databases for recent articles (1958-2022) published in English-focusing on the outbreaks of monkeypox disease, epidemiology, pathogenesis, aetiology, prevention, and control in endemic and non-endemic countries. Keywords such as \"Monkeypox\", \"Monkeypox virus\", \"Poxviridae\", \"Orthopoxvirus\", \"Smallpox\", and \"Smallpox Vaccine\" were considered in our search based on MESH medical subject headings. <b>Results:</b> Our review highlights four important findings. First, a cumulative of 1285 monkeypox cases have been documented and reported by the WHO in non-endemic countries as of June 8, 2022. Second, international travel contributes to the increase in cases in non-endemic countries. Third, the origin of the outbreak, the pattern of transmission, and the risk of infections is not fully understood. Fourth, there is an ongoing effort by the WHO, CDC, and other international health organization to control the spread of the monkeypox disease. <b>Conclusion:</b> Our findings underline the need to reassess research priorities on the origin, transmission pattern, and risk factors for infection of monkeypox. Also, we provide recommendations under the One Health spectrum to prevent further spread of the disease.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":"13 1","pages":"1-9"},"PeriodicalIF":4.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257565/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9627314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"FANTASTIC lifestyle questionnaire from 1983 until 2022: A review.","authors":"Patrícia Batista,&nbsp;João Neves-Amado,&nbsp;Anabela Pereira,&nbsp;João Amado","doi":"10.34172/hpp.2023.11","DOIUrl":"https://doi.org/10.34172/hpp.2023.11","url":null,"abstract":"<p><strong>Background: </strong>Studying lifestyles has always been important; quantifying them has become more complex. However, a questionnaire produced in 1983 has shown that its simple form of evaluation can be an added value in understanding lifestyles. Our aim is a systematic review of the scientific literature about the use of the FANTASTIC Lifestyle questionnaire (FLQ).</p><p><strong>Methods: </strong>The reflective systematic literature review on PubMed, Medline, Science Direct, and SCIELO databases with the descriptors \"FANTASTIC Lifestyle questionnaire\" OR \"FANTASTICO questionnaire\" OR \"FANTASTIC questionnaire\" OR \"FANTASTIC survey\" OR \"FANTASTIC checklist\". PRISMA criteria reporting of systematic reviews and meta-analyses were applied. The inclusion criteria were the use of FLQ instrument to measure lifestyles, presenting quantitative or qualitative results, and psychometric studies. It excluded other lifestyle instruments, incomplete articles, and non-English, Brazilian, Spanish, and Portuguese language articles.</p><p><strong>Results: </strong>Findings reveal 41 scientific articles included in the study. It analyzed the results and most studies use the instrument to assess all dimensions. However, some studies reported assessing specific dimensions such as nutrition, sleep, stress, tobacco, alcohol, and drugs. The questionnaire has been applied to a wide range of ages and literacy levels.</p><p><strong>Conclusion: </strong>This literature review allowed us to conclude that this questionnaire is still in use today and is applied in several contexts and populations. It is also possible to verify the relevance of its use and to design intervention strategies and programs for a healthy society. It is essential to draw attention to this issue and promote health literacy (HL) on this topic.</p>","PeriodicalId":46588,"journal":{"name":"Health Promotion Perspectives","volume":"13 2","pages":"88-98"},"PeriodicalIF":4.4,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10046190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}